Tacrolimus in Patients With Interstitial Pneumonia Associated With Polymyositis or Dermatomyositis: Interim Report of Postmarketing Surveillance in Japan.

Kuwana, Masataka; Wakasugi, Naoko; Furuya, Toshinori; Uno, Satoshi; Suda, Takafumi

Kuwana, Masataka; Wakasugi, Naoko; Furuya, Toshinori; Uno, Satoshi; Suda, Takafumi.

Affiliation

Kuwana M; M. Kuwana, MD, PhD, Department of Allergy and Rheumatology, Nippon Medical School Graduate School of Medicine, Tokyo; kuwanam@nms.ac.jp.
Wakasugi N; N. Wakasugi, MSc, T. Furuya, MSc, S. Uno, MSc, Astellas Pharma Inc., Tokyo.
Furuya T; N. Wakasugi, MSc, T. Furuya, MSc, S. Uno, MSc, Astellas Pharma Inc., Tokyo.
Uno S; N. Wakasugi, MSc, T. Furuya, MSc, S. Uno, MSc, Astellas Pharma Inc., Tokyo.
Suda T; T. Suda, MD, Second Department of Internal Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan.

J Rheumatol ; 49(7): 707-718, 2022 07.

Article in En | MEDLINE | ID: mdl-35428708

Subject(s)

Dermatomyositis; Lung Diseases, Interstitial; Polymyositis; Adrenal Cortex Hormones/adverse effects; Dermatomyositis/complications; Dermatomyositis/diagnosis; Dermatomyositis/drug therapy; Humans; Immunosuppressive Agents/adverse effects; Japan; Lung Diseases, Interstitial/diagnosis; Polymyositis/drug therapy; Polymyositis/epidemiology; Prospective Studies; Retrospective Studies; Tacrolimus/adverse effects

Key words

dermatomyositis; immunosuppressive agent; interstitial lung disease; polymyositis; postmarketing product surveillance

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Polymyositis / Lung Diseases, Interstitial / Dermatomyositis Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: J Rheumatol Year: 2022 Type: Article

Fulltext

XML

PubMed Links

Search on Google